# China NMPA Drug Inspection - Anhui Yuanhetang Pharmaceutical Co., Ltd. and 15 other companies - 17 batches of Chinese herbal medicine slices

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anhui-yuanhetang-pharmaceutical-co-ltd-and-15-other-companies/37a7c09a-fd60-4bf4-a1fc-eb70fd4d6f57/
Source feed: China

> China NMPA drug inspection for Anhui Yuanhetang Pharmaceutical Co., Ltd. and 15 other companies published November 18, 2019. Drug: 17 batches of Chinese herbal medicine slices. The Shandong Provincial Drug Administration issued an announcement on November 18, 2019, detailing the outcomes of drug 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shandong Provincial Drug Administration's Drug Quality Sampling Inspection Announcement (Issue 1, 2019)
- Company Name: Anhui Yuanhetang Pharmaceutical Co., Ltd. and 15 other companies
- Publication Date: 2019-11-18
- Drug Name: 17 batches of Chinese herbal medicine slices
- Inspection Finding: The quality does not meet the standard requirements.
- Action Taken: Control measures such as sealing, seizure, suspension of sales, and product recall have been taken, and cases have been filed or are being filed against the relevant production enterprises and sampled units in accordance with relevant laws and regulations.
- Summary: The Shandong Provincial Drug Administration issued an announcement on November 18, 2019, detailing the outcomes of drug quality sampling inspections carried out by the Shandong Provincial Institute for Food and Drug Control and other accredited testing institutions. These inspections identified significant quality standard non-compliance across 18 batches of pharmaceutical products. Notably, one batch of medicine produced by Zuojinming Pharmaceutical Co., Ltd. was found to be unqualified. Furthermore, 17 batches of traditional Chinese medicine decoction pieces from 15 enterprises, including Anhui Yuanhetang Pharmaceutical Co., Ltd., also failed to meet the required quality standards. 

Under the regulatory framework of the Shandong Provincial Drug Administration, municipal authorities have implemented stringent control measures, including sealing, seizing, suspending sales, and recalling the substandard products. Investigations and legal proceedings have been initiated or are in progress against the implicated manufacturers and sampling units. The authorities are also tasked with enhancing supervision of these products and companies to ensure thorough root cause analysis, the development and execution of effective rectification measures, and the comprehensive elimination of any associated risks to public health and safety.

Company: https://www.globalkeysolutions.net/companies/anhui-yuanhetang-pharmaceutical-co-ltd-and-15-other-companies/1670cc8c-747a-4490-815b-918ffb1f701c/